“Determination of receptor and HER2 status of breast cancer using tissue matrix technology. Validation of the method”, Вопр. онкол., vol. 62, no. 2, pp. 314–319, Dec. 2016, doi: 10.37469/0507-3758-2016-62-2-314-319.